Pancreatic Cancer Research

ResearcherKobe University HospitalActive in the last 2 years

Tomoo Itoh

Matched on ORCID iD 0000-0003-1498-5018; OpenAlex author ID A5102866035, A5103431709. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 4 papers · 2024: 4 papers

Papers 12

  1. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-023-02069-5↗
  2. Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study. Co-author DOI 10.1007/s00535-024-02149-0↗
  3. A case of pancreatic ductal adenocarcinoma with enteroblastic, neuroendocrine, and squamous differentiation with p53 overexpression and loss of Rb expression. Last author DOI 10.1016/j.ijscr.2024.109854↗
  4. Cultures derived from pancreatic cancer xenografts with long-term gemcitabine treatment produce chemoresistant secondary xenografts: Establishment of isogenic … Co-author DOI 10.1016/j.prp.2024.155632↗
  5. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-022-01939-8↗
  6. A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal… Co-author DOI 10.1007/s00535-023-02020-8↗
  7. Benefits of pancreatic parenchymal endoscopic ultrasonography in predicting microscopic precancerous lesions of pancreatic cancer. Co-author DOI 10.1038/s41598-023-38920-1↗
  8. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Anal… Co-author DOI 10.1245/s10434-023-13569-2↗
  9. Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm. Co-author DOI 10.1245/s10434-022-11704-z↗
  10. Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients. Co-author DOI 10.1097/mpa.0000000000001438↗
  11. High-grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the… Co-author DOI 10.1111/his.13629↗
  12. The CD40-CD154 interaction would correlate with proliferation and immune escape in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jso.21812↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Tsujimae · 7 shared papers, 2022–2024 · strength 0.93
  2. Atsuhiro Masuda · 7 shared papers, 2022–2024 · strength 0.93
  3. Takashi Kobayashi · 7 shared papers, 2022–2024 · strength 0.93
  4. Hirochika Toyama · 7 shared papers, 2022–2024 · strength 0.93
  5. Arata Sakai · 7 shared papers, 2022–2024 · strength 0.93
  6. Yuzo Kodama · 7 shared papers, 2022–2024 · strength 0.93
  7. Keitaro Sofue · 6 shared papers, 2022–2024 · strength 0.78
  8. Shigeto Masuda · 6 shared papers, 2022–2024 · strength 0.76
  9. Kohei Yamakawa · 6 shared papers, 2022–2024 · strength 0.76
  10. Shohei Abe · 6 shared papers, 2022–2024 · strength 0.76
  11. Takeshi Tanaka · 6 shared papers, 2022–2024 · strength 0.76
  12. Takumi Fukumoto · 6 shared papers, 2022–2024 · strength 0.76
  13. Masanori Gonda · 6 shared papers, 2022–2024 · strength 0.76
  14. Mika Miki · 5 shared papers, 2023–2024 · strength 0.69
  15. Shigeto Ashina · 5 shared papers, 2022–2023 · strength 0.62
  16. Yoshiyuki Harada · 4 shared papers, 2023–2024 · strength 0.53
  17. Ryota Nakano · 3 shared papers, 2022–2024 · strength 0.40
  18. Ken Sasai · 2 shared papers, 2019–2024 · strength 0.36
  19. Takayuki Kodama · 1 shared paper, 2024 · strength 0.31
  20. Mamoru Takenaka · 2 shared papers, 2023–2024 · strength 0.29
  21. Yasuyo Kobayashi-Ooka · 1 shared paper, 2024 · strength 0.26
  22. Tsuyoshi Hamada · 2 shared papers, 2023 · strength 0.25
  23. Takuya Ikegawa · 2 shared papers, 2022–2023 · strength 0.23
  24. Hidekazu Tanaka · 1 shared paper, 2024 · strength 0.16
  25. Tomonori Matsumoto · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.